These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 21953756)

  • 61. Contemporary percutaneous treatment of infrapopliteal arterial disease: a practical approach.
    Golzar JA; Belur A; Carter LI; Choksi N; Safian RD; O'Neill WW
    J Interv Cardiol; 2007 Jun; 20(3):222-30. PubMed ID: 17524115
    [No Abstract]   [Full Text] [Related]  

  • 62. Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials.
    Acin F; de Haro J; Bleda S; Varela C; Esparza L
    J Endovasc Ther; 2012 Oct; 19(5):585-95. PubMed ID: 23046322
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Percutaneous vascular interventions in the superficial femoral artery. A review.
    Wiesinger B; Heller S; Schmehl J; Claussen CD; Wiskirchen J; Tepe G
    Minerva Cardioangiol; 2006 Feb; 54(1):83-93. PubMed ID: 16467744
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Primary nitinol stenting for femoropopliteal disease.
    Mewissen MW
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II63-81. PubMed ID: 19624075
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Femoropopliteal artery obstructions: from the balloon to the stent-graft.
    Lammer J
    Cardiovasc Intervent Radiol; 2001; 24(2):73-83. PubMed ID: 11443390
    [No Abstract]   [Full Text] [Related]  

  • 66. Letter by Chalmers regarding article "Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial".
    Chalmers N
    Circ Cardiovasc Interv; 2010 Oct; 3(5):e22; author reply e23. PubMed ID: 20959593
    [No Abstract]   [Full Text] [Related]  

  • 67. Thrombogenicity of the Hemobahn/Viabahn in the SFA.
    Bray PJ; Bray AE
    J Endovasc Ther; 2006 Dec; 13(6):783-4. PubMed ID: 17154713
    [No Abstract]   [Full Text] [Related]  

  • 68. Combined angioplasty with the Kensey catheter and balloon angioplasty in occlusive arterial disease. A preliminary report.
    Lukes P; Wihed A; Tidebrant G; Risberg B; Ortenwall P; Seeman T
    Acta Radiol; 1992 May; 33(3):230-3. PubMed ID: 1534252
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Below-the-ankle angioplasty and stenting for limb salvage: anatomical considerations and long-term outcomes.
    Katsanos K; Diamantopoulos A; Spiliopoulos S; Karnabatidis D; Siablis D
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):926-35. PubMed ID: 23152042
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease.
    Davies MG; Waldman DL; Pearson TA
    J Am Coll Surg; 2005 Aug; 201(2):275-96. PubMed ID: 16038827
    [No Abstract]   [Full Text] [Related]  

  • 71. [Interventional angiography].
    Mahler F; Do D; Triller J
    Schweiz Med Wochenschr; 1991 Dec; 121(51-52):1931-5. PubMed ID: 1837172
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Below-the-knee revascularization. Advanced techniques.
    SCHWARZWALDER U; ZELLER T
    J Cardiovasc Surg (Torino); 2009 Oct; 50(5):627-34. PubMed ID: 19741578
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Standard balloon angioplasty versus angioplasty with paclitaxel-eluting balloons for femoropopliteal artery stenosis.
    Ju MH; Rodríguez HE
    J Cardiovasc Surg (Torino); 2012 Aug; 53(4):459-63. PubMed ID: 22854525
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Commentary: Outback catheter in femoropopliteal subintimal angioplasty: new horizons in treating chronic total occlusions.
    Setacci C; Sirignano P; Setacci F
    J Endovasc Ther; 2011 Feb; 18(1):22-4. PubMed ID: 21314344
    [No Abstract]   [Full Text] [Related]  

  • 75. Recanalization of femoropopliteal chronic total occlusions using the ENABLER-P Balloon Catheter System.
    Zeller T; Kambara AM; Moreira SM; Atar E; Chulsky A; Turgeman Y; Sixt S; Tepe G; Rastan A; Buchbinder M
    J Endovasc Ther; 2012 Apr; 19(2):131-9. PubMed ID: 22545874
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mid-term clinical outcome and predictors of vessel patency after femoropopliteal stenting with self-expandable nitinol stent.
    Soga Y; Iida O; Hirano K; Yokoi H; Nanto S; Nobuyoshi M
    J Vasc Surg; 2010 Sep; 52(3):608-15. PubMed ID: 20573476
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Incidence, anatomical location, and clinical significance of compressions and fractures in infrapopliteal balloon-expandable metal stents.
    Karnabatidis D; Katsanos K; Spiliopoulos S; Diamantopoulos A; Kagadis GC; Siablis D
    J Endovasc Ther; 2009 Feb; 16(1):15-22. PubMed ID: 19281287
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The treatment of femoropopliteal in-stent restenosis: back to the future.
    Laird JR; Yeo KK
    J Am Coll Cardiol; 2012 Jan; 59(1):24-5. PubMed ID: 22192664
    [No Abstract]   [Full Text] [Related]  

  • 79. Regarding "Stenting for femoropopliteal lesions".
    Schillinger M; Minar E
    J Vasc Surg; 2008 Jul; 48(1):252; author reply 252-3. PubMed ID: 18589243
    [No Abstract]   [Full Text] [Related]  

  • 80. Devices for infrainguinal endovascular therapy: menu à la carte or table d'hôte?
    Biondi-Zoccai G; Sangiorgi G; Modena MG
    J Endovasc Ther; 2011 Oct; 18(5):638-41. PubMed ID: 21992632
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.